The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
Open accessAbstract
Vascular endothelial growth factor (VEGF) is a regulator of vasculogenesis and angiogenesis. To investigate the role of nitric oxide (NO) in VEGF-induced proliferation and in vitro angiogenesis, human umbilical vein endothelial cells (HUVEC) were used. VEGF stimulated the growth of HUVEC in an NO-dependent manner. In addition, VEGF promoted the NO-dependent formation of network-like structures in HUVEC cultured in three dimensional (3D) collagen gels. Exposure of cells to VEGF led to a concentration-dependent increase in cGMP levels, an indicator of NO production, that was inhibited by nitro-L-arginine methyl ester. VEGF-stimulated NO production required activation of tyrosine kinases and increases in intracellular calcium, since tyrosine kinase inhibitors and calcium chelators attenuated VEGF-induced NO release. Moreover, two chemically distinct phosphoinositide 3 kinase (PI-3K) inhibitors attenuated NO release after VEGF stimulation. In addition, HUVEC incubated with VEGF for 24 h showed an increase in the amount of endothelial NO synthase (eNOS) protein and the release of NO. In summary, both short- and long-term exposure of human EC to VEGF stimulates the release of biologically active NO. While long-term exposure increases eNOS protein levels, short-term stimulation with VEGF promotes NO release through mechanisms involving tyrosine and PI-3K kinases, suggesting that NO mediates aspects of VEGF signaling required for EC proliferation and organization in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Inositol phosphates and cell signalling
Berridge, M. J., & Irvine, R. F. (1989) · Nature · doi:10.1038/341197a0 · Cited by 4,058
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J., & Bicknell, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119451 · Cited by 915
Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H. J., Maggi, C. A., Geppetti, P., & Ledda, F. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117557 · Cited by 861
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
Clauss, M., Weich, H., Breier, G., Knies, U., Röckl, W., Waltenberger, J., & Risau, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17629 · Cited by 836
Roles of nitric oxide in tumor growth.
Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., & Moncada, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4392 · Cited by 780
Zeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726 · cited 2×
“This is in agreement with previous observations that PI-3K inhibition blocks insulin and IGF-1–induced NO production in HUVEC (43).”
BackgroundResultXia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566
Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent
Thomas, K. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.603 · Cited by 556
Carpenter, C. L., & Cantley, L. C. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80060-3 · Cited by 534
Guo, D., Jia, Q., Song, H.-Y., Warren, R. S., & Donner, D. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6729 · Cited by 482
Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., & Dvorak, H. F. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_10 · Cited by 472
Abedi, H., & Zachary, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15442 · Cited by 471
Tumor-promoting phorbol esters induce angiogenesis in vitro
Montesano, R., & Orci, L. (1985) · Cell · doi:10.1016/0092-8674(85)90104-7 · Cited by 464
Goto, F., Goto, K., Weindel, K., & Folkman, J. (1993) · PubMed · Cited by 459
The Nitric Oxide Synthase Family of Proteins
Sessa, W. C. (1994) · Journal of Vascular Research · doi:10.1159/000159039 · Cited by 456
Self-citationVascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
Ku, D. D., Zaleski, J. K., Liu, S., & Brock, T. A. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.2.h586 · Cited by 445
Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
Morbidelli, L., Chang, C. H., Douglas, J. G., Granger, H. J., Ledda, F., & Ziche, M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.1.h411 · Cited by 417
van der Zee, R., Murohara, T., Luo, Z., Zollmann, F., Passeri, J., Lekutat, C., & Isner, J. M. (1997) · Circulation · doi:10.1161/01.cir.95.4.1030 · Cited by 403
Rosenkranz-Weiss, P., Sessa, W. C., Milstien, S., Kaufman, S., Watson, C. A., & Pober, J. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117221 · Cited by 362 · cited 2×
“Interestingly, stimulation of HUVEC with cytokines results in increased NO production through eNOS, that is due to increased synthesis of tetrahydrobiopterin, a necessary cofactor for all NOS isoforms that is depleted in serially passaged HUVEC (28).”
BackgroundMethodSelf-citationVascular endothelial growth factor
Ferrara, N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00387-5 · Cited by 355
Sequential protein kinase reactions controlling cell growth and differentiation
Johnson, G. L., & Vaillancourt, R. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90141-4 · Cited by 335
Role of Vegf-Flt Receptor System in Normal and Tumor Angiogenesis
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60716-2 · Cited by 323
Tsukahara, H., Gordienko, D. V., Tonshoff, B., Gelato, M. C., & Goligorsky, M. S. (1994) · Kidney International · doi:10.1038/ki.1994.78 · Cited by 323
Brock, T. A., Dvorak, H. F., & Senger, D. R. (1991) · PubMed · Cited by 321
Ayajiki, K., Kindermann, M., Hecker, M., Fleming, I., & Busse, R. (1996) · Circulation Research · doi:10.1161/01.res.78.5.750 · Cited by 285
Sessa, W. C., Garca-Cardea, G., Liu, J., Keh, A., Pollock, J. S., Bradley, J., Thiru, S., Braverman, I. M., & Desai, K. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17641 · Cited by 258
Self-citationLiu, J., García-Cardeña, G., & Sessa, W. C. (1996) · Biochemistry · doi:10.1021/bi961720e · Cited by 250
Self-citationEffects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac Performance
Yang, R., Thomas, G. R., Bunting, S., Ko, A., Ferrara, N., Keyt, B., Ross, J., & Jin, H. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199606000-00011 · Cited by 244
VEGF induces NO-dependent hyperpermeability in coronary venules
Wu, H. M., Huang, Q., Yuan, Y., & Granger, H. J. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.6.h2735 · Cited by 243
Pawson, T. J. (1988) · PubMed · Cited by 243
Leibovich, S. J., Polverini, P. J., Fong, T. W., Harlow, L. A., & Koch, A. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4190 · Cited by 195
Inoue, N., Venema, R. C., Sayegh, H. S., Ohara, Y., Murphy, T. J., & Harrison, D. G. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.8.1255 · Cited by 192
Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers
Konturek, S. J., Brzozowski, T., Majka, J., Pytko-Polonczyk, J., & Stachura, J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90997-v · Cited by 185
Fleming, I., Fisslthaler, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.4.522 · Cited by 176
Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature
Andrade, S. P., Hart, I. R., & Piper, P. J. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13412.x · Cited by 175
Evidence that nitric oxide is an endogenous antiangiogenic mediator
Pipili‐Synetos, E., Sakkoula, E., Haralabopoulos, G., Andriopoulou, P., Peristeris, P., & Maragoudakis, M. E. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14822.x · Cited by 163
Sankar, S., Mahooti-Brooks, N., Bensen, L., McCarthy, T. L., Centrella, M., & Madri, J. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118565 · Cited by 159
Self-citationPermissive Role of Nitric Oxide in Endothelin-induced Migration of Endothelial Cells
Noiri, E., Hu, Y., Bahou, W. F., Keese, C. R., Giæver, I., & Goligorsky, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1747 · Cited by 156
Barleon, B., Hauser, S., Schöllmann, C., et al. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540107 · Cited by 143
The Lipid Products of Phosphoinositide 3-Kinase Increase Cell Motility through Protein Kinase C
Derman, M. P., Toker, A., Hartwig, J. H., Spokes, K., Falck, J. R., Chen, C., Cantley, L. C., & Cantley, L. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6465 · Cited by 131
Brown, L. F., Detmar, M. J., Tognazzi, K., Abu‐Jawdeh, G. M., & Iruela‐Arispe, M. L. (1997) · PubMed · Cited by 130
Papapetropoulos, A., Desai, K. M., Rudic, R. D., Mayer, B., Zhang, R., Ruiz‐Torres, M. P., García‐Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Europe PMC (PubMed Central) · Cited by 119
Self-citationPhosphoinositide 3-kinase and the regulation of cell growth
Carpenter, C. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00018-2 · Cited by 118
Marczin, N., Papapetropoulos, A., & Catravas, J. D. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.3.h1014 · Cited by 88
Self-citationInterdependence of Calcium Signaling and Protein Tyrosine Phosphorylation in Human Endothelial Cells
Fleming, I., Fißlthaler, B., & Busse, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.11009 · Cited by 80
Kanno, K., Hirata, Y., Tasuku, I. M. A. I., Iwashina, M., & Marumo, F. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.6.h2318 · Cited by 77
Rooman, I., Schuit, F., & Bouwens, L. (1997) · PubMed · Cited by 74
Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats.
Papapetropoulos, A., Marczin, N., Snead, M. D., Cheng, C., Milici, A., & Catravas, J. D. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.476 · Cited by 52
Self-citationcGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue
Papapetropoulos, A., Cziráki, A., Rubin, J. W., Stone, C. D., & Catravas, J. D. (1996) · Journal of Cellular Physiology · Cited by 43
Self-citationCoronary arteriolar flow-induced vasodilation signals through tyrosine kinase
Muller‐Delp, J. M., Davis, M. J., & Chilian, W. M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.6.h1878 · Cited by 32
Potent inhibition of angiogenesis by wortmannin, a fungal metabolite
Oikawa, T., & Shimamura, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00864-3 · Cited by 26
Vascular Endothelial Growth Factor
Ferrara, N. (2007) · CRC Press eBooks · doi:10.1201/9781420004298.ch2 · Cited by 15
Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase.
Oikawa, T., ASHING, H., Shimamura, M., Hasegawa, M., Morita, I., Murota, S., Ishizuka, M., & TAKEUCHI, T. (1993) · The Journal of Antibiotics · doi:10.7164/antibiotics.46.785 · Cited by 12
Cited by
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Self-citationSoluble endoglin contributes to the pathogenesis of preeclampsia
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1429 · Cited by 1,855
“Several studies support the hypothesis that decreased biologically available NO is central to the pathogenesis of preeclampsi”
BackgroundHussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Metadata
- Authors
- Papapetropoulos, A., García-Cardeña, G., Madri, J. A., & Sessa, W. C.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-12-15
- Volume
- 100
- Issue
- 12
- Pages
- 3131-3139
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2041034845
- Cited by
- 1,191
- References
- 64
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.